Tokyo, Japan

Hajime Sogabe


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hajime Sogabe: Innovator in Propanolamine Derivatives

Introduction

Hajime Sogabe is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on propanolamine derivatives. With a total of 2 patents, Sogabe's innovations have the potential to impact various medical treatments.

Latest Patents

One of Sogabe's latest patents involves new propanolamine derivatives or salts thereof. This invention is represented by a specific formula and is designed to have gut-selective sympathomimetic, anti-ulcerous, anti-pancreatitis, lipolytic, anti-urinary incontinence, and anti-pollakiuria activities. The patent also covers processes for the preparation of these derivatives, pharmaceutical compositions that include them, and methods for preventing and/or treating diseases as indicated in the specification for both humans and animals.

Career Highlights

Throughout his career, Hajime Sogabe has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His work in these organizations has contributed to his expertise and the development of his patented inventions.

Collaborations

Sogabe has collaborated with several professionals in his field, including Kiyoshi Taniguchi and Minoru Sakurai. These collaborations have likely enriched his research and development efforts.

Conclusion

Hajime Sogabe is a distinguished inventor whose work on propanolamine derivatives showcases his innovative spirit and dedication to advancing pharmaceutical science. His contributions are poised to make a significant impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…